338 related articles for article (PubMed ID: 9239576)
21. Selective enhancement of antitumor activity of N-acetyl melphalan upon conjugation to monoclonal antibodies.
Smyth MJ; Pietersz GA; McKenzie IF
Cancer Res; 1987 Jan; 47(1):62-9. PubMed ID: 3791221
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
[TBL] [Abstract][Full Text] [Related]
23. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
Thomsen AE; Christensen MS; Bagger MA; Steffansen B
Eur J Pharm Sci; 2004 Dec; 23(4-5):319-25. PubMed ID: 15567284
[TBL] [Abstract][Full Text] [Related]
24. Chemical modification of melphalan as a key to improving treatment of haematological malignancies.
Gajek A; Poczta A; Łukawska M; Cecuda-Adamczewska V; Tobiasz J; Marczak A
Sci Rep; 2020 Mar; 10(1):4479. PubMed ID: 32161295
[TBL] [Abstract][Full Text] [Related]
25. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
26. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
Roboz J; Jiang J; Holland JF; Bekesi JG
Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
[TBL] [Abstract][Full Text] [Related]
27. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
28. Modulation of melphalan resistance in glioma cells with a peripheral benzodiazepine receptor ligand-melphalan conjugate.
Kupczyk-Subotkowska L; Siahaan TJ; Basile AS; Friedman HS; Higgins PE; Song D; Gallo JM
J Med Chem; 1997 May; 40(11):1726-30. PubMed ID: 9171882
[TBL] [Abstract][Full Text] [Related]
29. Activity of hydrolytic enzymes in tumour cells is a determinant for anti-tumour efficacy of the melphalan containing prodrug J1.
Gullbo J; Wickström M; Tullberg M; Ehrsson H; Lewensohn R; Nygren P; Luthman K; Larsson R
J Drug Target; 2003 Jul; 11(6):355-63. PubMed ID: 14668056
[TBL] [Abstract][Full Text] [Related]
30. Uptake of cyclic dipeptide by PEPT1 in Caco-2 cells: phenolic hydroxyl group of substrate enhances affinity for PEPT1.
Mizuma T; Narasaka T; Awazu S
J Pharm Pharmacol; 2002 Sep; 54(9):1293-6. PubMed ID: 12356285
[TBL] [Abstract][Full Text] [Related]
31. Transport of free and peptide-bound pyrraline at intestinal and renal epithelial cells.
Hellwig M; Geissler S; Peto A; Knütter I; Brandsch M; Henle T
J Agric Food Chem; 2009 Jul; 57(14):6474-80. PubMed ID: 19555106
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-p-L-fluorophenylalanine ethyl ester) and P2 (L-prolyl-m-L-sarcolysyl-p-L-fluorophenylalanine ethyl ester): comparison with melphalan.
Gullbo J; Dhar S; Luthman K; Ehrsson H; Lewensohn R; Nygren P; Larsson R
Anticancer Drugs; 2003 Sep; 14(8):617-24. PubMed ID: 14501383
[TBL] [Abstract][Full Text] [Related]
33. Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Bhatnagar PK; Takata JS; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Aug; 13(8):1213-8. PubMed ID: 8865315
[TBL] [Abstract][Full Text] [Related]
34. Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
Chrzanowski K; Pałka J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():209-11. PubMed ID: 11820612
[TBL] [Abstract][Full Text] [Related]
35. The anti-leishmanial activity of dipeptide esters on Leishmania amazonensis amastigotes.
Ramazeilles C; Juliano L; Chagas JR; Rabinovitch M
Parasitology; 1990 Apr; 100 Pt 2():201-7. PubMed ID: 2345655
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability.
Orioli M; Vistoli G; Regazzoni L; Pedretti A; Lapolla A; Rossoni G; Canevotti R; Gamberoni L; Previtali M; Carini M; Aldini G
ChemMedChem; 2011 Jul; 6(7):1269-82. PubMed ID: 21634010
[TBL] [Abstract][Full Text] [Related]
37. Effects of lead on viability and intracellular metal content of C6 rat glioma cells.
Tiffany-Castiglioni E; Garcia DM; Wu JN; Zmudzki J; Bratton GR
J Toxicol Environ Health; 1988; 23(2):267-79. PubMed ID: 3343700
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form.
Geissler S; Hellwig M; Markwardt F; Henle T; Brandsch M
Eur J Pharm Biopharm; 2011 May; 78(1):75-82. PubMed ID: 21216287
[TBL] [Abstract][Full Text] [Related]
39. Bivalent bendamustine and melphalan derivatives as anticancer agents.
Scutaru AM; Wenzel M; Gust R
Eur J Med Chem; 2011 May; 46(5):1604-15. PubMed ID: 21371790
[TBL] [Abstract][Full Text] [Related]
40. A tandem mass spectrometric investigation of N-(3-ferrocenyl-2-naphthoyl) dipeptide ethyl esters and N-(6-ferrocenyl-2-naphthoyl) dipeptide ethyl esters.
Rai DK; Mooney Á; Kenny PT
Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2905-10. PubMed ID: 21913269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
